Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cleviprex clevidipine: Phase III data

The Medicines Co. (MDCO), Parsippany, N.J.
Product: Cleviprex clevidipine
Business: Cardiovascular
Molecular target: Ca

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE